🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Douglas H. Thamm

University of Colorado Cancer Center

ORCID: 0000-0002-8914-7767

Also affiliated with University of Colorado Denver, Colorado State University

MedicineBiochemistry, Genetics and Molecular BiologyVeterinary

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma”.

Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2105

N/A

0DataRank · unranked

84 citations

Lyndah Chow, Sunetra Das, Laurel A. Haines, Eric P. Palmer, Jade Kurihara +6 more

Inertial focusing of circulating tumor cells in whole blood at high flow rates using the microfluidic CTCKey™ device for CTC enrichment

Lab on a Chip(2021)10.1039/d1lc00546d

N/A

0DataRank · unranked

36 citations

Jessica Antoinette Jana, Anna Kaehr, Emma Purcell, Tyler Opdycke, Costanza Paoletti +5 more

Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma

Communications Biology(2021)10.1038/s42003-021-02683-0

N/A

0DataRank · unranked

29 citations

Rupa Idate, Daniel P. Regan, Jared S. Fowles, Susan E. Lana, Douglas H. Thamm +3 more

Canine Non-Angiogenic, Non-Myogenic Splenic Stromal Sarcoma: a Retrospective Clinicopathological Analysis and Investigation of Podoplanin as a Marker of Tumour Histogenesis

Journal of Comparative Pathology(2021)10.1016/j.jcpa.2021.07.006

N/A

0DataRank · unranked

8 citations

Douglas H. Thamm, Eric P. Palmer, Daniel P. Regan, Brittany M. Wittenberns

Whole exome sequencing and gene expression analysis of canine osteosarcomas identify mutant TP53 and enriched immune pathways associated with longer survival

Research Square(2021)10.21203/rs.3.rs-135094/v1

N/A

0DataRank · unranked

0 citations

Rupa Idate, Daniel P. Regan, Jared S. Fowles, Susan E. Lana, Douglas H. Thamm +3 more

Review: NF-kB activation in canine cancer

Veterinary Pathology(2022)10.1177/03009858221092017

N/A

0DataRank · unranked

31 citations

Douglas H. Thamm, Lisa J. Schlein

Tumor-associated macrophages: Prognostic and therapeutic targets for cancer in humans and dogs

Frontiers in Immunology(2023)10.3389/fimmu.2023.1176807

N/A

0DataRank · unranked

35 citations

Douglas H. Thamm, Rachel V. Brady

Design of a randomized, placebo-controlled study evaluating efficacy and safety of a cancer preventative vaccine in dogs

Veterinary Immunology and Immunopathology(2023)10.1016/j.vetimm.2023.110691

N/A

0DataRank · unranked

8 citations

Stephen Albert Johnston, David M. Vail, Jens C. Eickhoff, Kathryn Sykes, Justin R. Brown +15 more

Parthenolide As a Therapeutic for Disseminated Canine Neoplasms

Journal of Pharmacology and Experimental Therapeutics(2023)10.1124/jpet.123.001851

N/A

0DataRank · unranked

0 citations

Samuel A. Brill, Rachel V. Brady, Kristen B. Farrell, Barbara Rose, Travis Meuten +3 more

Validation of ferroptosis in canine cancer cells to enable comparative oncology and translational medicine

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.28.591561

N/A

0DataRank · unranked

1 citations

Gang Xing, Laura Furst, Krishna Dave, Qiong Zhou, Daniel V. LaBarbera +5 more